当前位置: 首页 > 期刊 > 《医学信息》 > 2019年第8期
编号:13390790
循环miRNA监测肝细胞癌的研究(4)
http://www.100md.com 2019年2月26日 《医学信息》 2019年第8期
     [10]Chakravarthi BV,Goswami MT,Pathi SS,et al.MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer[J].Oncogene,2016,35(49):6330-6340.

    [11]Wang HY,Yan LX,Shao Q,et al.Profiling Plasma MicroRNA in Nasopharyngeal Carcinoma with Deep Sequencing[J].Clinical Chemistry,2014,60(5):773-782.

    [12]Martinez-Quetglas I,Pinyol R,Dauch D,et al.IGF2 is Upregulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and is an Actionable Oncogene Product in Experimental Models[J].Gastroenterology,2016,151(6):1192-1205.
, 百拇医药
    [13]Tang S,Hu W,Hu J,et al.Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma[J].Liver International,2015,35(2):608-619.

    [14]Tang S,Chen Y,Feng S,et al.MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma[J].Oncotarget,2017,8(59):99871-99888.

    [15]Song F,Chen WX,Lv XB,et al.miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1[J].Cancer Letters,2015,362(2):183-191.
, 百拇医药
    [16]Song Q,Xu Y,Yang C,et al.miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM[J].Cancer Research,2014,74(11):3031-3042.

    [17]Shi L,Liu S,Zhao W,et al.miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome[J].Reprod Biomed Online,2015,31(4):565-572.

    [18]Chen K,He H,Xie Y,et al.miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis[J].Sci Rep,2015(5):11909.
, 百拇医药
    [19]Yang ZG,Ma XD,He ZH,et al.miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5[J].Int Braz J Urol,2017,43(6):1060-1067.

    [20]He M,Chen Z,Martin M,et al.miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal TransitionNovelty and Significance[J].Circulation Research,2017,120(2):354-365.

    [21]Chouri E,Servaas NH,Bekker CPJ,et al.Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis[J].Journal of Autoimmunity,2018,89(4):162-170.

    收稿日期:2019-3-9;修回日期:2019-3-19

    編辑/杨倩

    作者简介:赵瑶瑶(1994.6-),女,湖北孝感人,硕士,主要研究领域为分子生物学

    通讯作者:胡佳杰(1967.12-),男,湖北天门人,博士,副教授,研究方向为分子病毒学, 百拇医药(赵瑶瑶 高川 胡佳杰)
上一页1 2 3 4